PANELS
Ear, nose & throat
Home > Ear, Nose & Throat
Overview
Our virtual panels include over 3,000 genes selected based on the most up-to-date literature, gene reviews and variant databases. Our whole genome approach offers cost-effectiveness by reducing the need for multiple targeted tests, and maximises diagnostic yield by allowing you to combine panels, select individual genes, and surface variants across all regions of the genome.
Genetics in Ear, nose & throat
Genetic testing has become increasingly valuable in the field of ear, nose, and throat (ENT) medicine, providing clinicians with insights into the genetic underpinnings of various conditions and enabling more personalized care. Genetic testing plays a crucial role in diagnosing the genetic factors contributing to hearing loss, a common ENT issue. By identifying specific genetic mutations, clinicians can determine the cause of hearing loss, its progression, and whether it’s hereditary. This information aids in tailoring treatment options, such as cochlear implants or hearing aids, to the individual’s genetic profile.
Genetic testing is instrumental in diagnosing congenital disorders affecting the ears, nose, and throat. This information allows for proactive measures and lifestyle recommendations to mitigate these risks.
While genetic panel tests are highly valuable in ear, nose & throat, it’s essential to interpret their results in the context of a patient’s clinical presentation and other diagnostic tests. We recommend working closely with genetic counselors and other specialists to ensure that genetic information is used effectively to diagnose, treat, and manage ear, nose & throat conditions.
For further information on tailoring treatment plans to an individual’s genetic profile, leading to improved outcomes and reduced side effects, please visit our pharmacogenomics page.
